A Potential Therapeutic Strategy Involving Short-Term Prednisone and Methotrexate for Patients with Polymyalgia Rheumatica - Summary - MDSpire

A Potential Therapeutic Strategy Involving Short-Term Prednisone and Methotrexate for Patients with Polymyalgia Rheumatica

  • By

  • Edoardo Conticini

  • Raffaele Truscelli

  • Silvia Grazzini

  • Paolo Falsetti

  • Caterina Baldi

  • Alessandra Cartocci

  • Luca Cantarini

  • Bruno Frediani

  • February 26, 2026

  • 0 min

Share

Objective:

Emphasize the exclusion of subclinical GCA more explicitly.

Key Findings:
  • Include specific statistical results to enhance credibility.
Interpretation:

Mention implications for clinical practice.

Limitations:
  • Include potential confounding factors related to the single-center design.
Conclusion:

Suggest specific next steps for research or clinical application.

Original Source(s)

A Potential Therapeutic Strategy Involving Short-Term Prednisone and Methotrexate for Patients with Polymyalgia Rheumatica

  • by Edoardo Conticini, Raffaele Truscelli, Silvia Grazzini, Paolo Falsetti, Caterina Baldi, Alessandra Cartocci, Luca Cantarini, Bruno Frediani

  • February 26, 2026

Related Content

Neutrophil extracellular traps and pyroptosis: a molecular nexus linking systemic autoimmune diseases to atherosclerosis

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.

A machine learning-based classification model for interstitial lung disease in rheumatoid arthritis